Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchselanktuftsingabaneuropeptides

Selank overview reviews tuftsin analog's proposed GABAergic and immune signaling

The heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro was engineered from tuftsin to improve stability while preserving regulatory activity.

PR
By Priya Raman · Science Reporter
Oct 15 15:57 ETSource: Valdosta Daily Times

The wire

  1. 01A background piece summarizes research on Selank, a synthetic tuftsin analog hypothesized to modulate GABAergic signaling indirectly rather than acting as a direct receptor agonist.
  2. 02Selank is widely sought in the research-peptide gray market, so clinicians and operators field questions about its evidence base.
  3. 03The article is a literature overview with no new data, and describes mechanisms as hypothesized and under active investigation.

From the source

Neurochemical Signaling: The Multifaceted Properties of the Selank Peptide

Among the growing number of synthetic regulatory peptides explored in modern molecular research, Selank continues to attract scientific interest because of its distinctive structural characteristics and its proposed interaction with multiple biological signaling networks. Originally developed as a synthetic analog derived from the naturally occurring immunomodulatory peptide tuftsin, Selank has gr

Read at valdostadailytimes.com
PeptiPrescribed peptides from $99/moSee all →